|
|
Treatment:
children over 5 years old |
|
|
Long-term preventive |
|
Quick-relief |
STEP 4
Severe persistent |
|
Daily medications: |
|
- |
Short-acting bronchodilator:
inhaled 2-agonist
PRN. |
|
- |
Inhaled corticosteroid (ICS), 800-2,000
mcg or more, and |
|
|
- |
Long-acting bronchodilator:
either long-acting inhaled 2-agonist
and/or sustained-release theophylline, and/or long-acting 2-agonist
tablets or syrup, and |
|
|
- |
Corticosteroid tablets or syrup long term |
|
|
|
|
|
|
|
|
|
|
STEP 3
Moderate persistent |
|
Daily medications: |
|
- |
Short-acting bronchodilator:
inhaled 2-agonist
PRN, not to exceed 3-4 times in one day |
|
- |
ICS, 500mcg
AND, if needed |
|
|
|
- |
Long-acting bronchodilator:
either long-acting inhaled 2-agonist,
sustained-release theophylline, or long-acting 2-agonist
tablets or syrup |
|
|
|
- |
Consider adding anti-leukotriene |
|
|
|
|
|
|
|
|
|
STEP 2
Mild persistent |
|
Daily medication: |
|
- |
Short-acting bronchodilator:
inhaled 2-agonist
PRN, not to exceed 3-4 times in one day |
|
- |
Either ICS, 200-500 mcg, or cromoglycate
or nedocromil or sustained release theophylline.
Anti-leukotrienes may be considered |
|
|
|
|
|
|
|
|
|
STEP 1
Intermittent |
|
- |
None needed |
|
- |
Short-acting bronchodilator:
inhaled 2-agonist
PRN, not less than once a week |
|
|
|
|
|
|
|
GINA = Global Initiative
for Asthma |